Navigation Links
New therapeutic target for lung cancer
Date:3/31/2011

A new therapeutic target for lung cancer has been discovered by researchers at Seoul National University. It was found that a variant of the protein AIMP2 is highly expressed in lung cancer cells and also that patients demonstrating high expression of this variant show lower survival. The study is published on March 31 in the open-access journal PLoS Genetics.

Lung cancer is one of the world's most common cancers and a leading cause of death resulting from cancer. Despite treatment with a combination of surgery, radiation and drugs, the survival rate for patients has not drastically improved over the past few decades. It had previously been shown that the protein AIMP2 acted as a tumor-suppressor by interacting with another oncosuppressor, p53. However, whether AIMP2 was indeed pathologically linked to human cancer had not been definitively proved. This investigation discovered that a variant of AIMP2 is highly expressed in human lung cancer cells. AIMP2-DX2 compromises the tumor-suppressing activity of AIMP2 by competitively binding to p53. It was also shown that suppression of AIMP2-DX2 slowed tumor growth, suggesting that this could be an exciting new therapeutic target.

New innovative therapies are important not only because of the high mortality rate associated with lung cancer, but because the majority of the drugs are cytotoxic, causing many adverse effects. These findings could create an opportunity to develop new innovative cancer drugs, as well as presenting a new target that could also be applied to other cancers.


'/>"/>

Contact: Sunghoon Kim
sungkim@snu.ac.kr
822-880-8180
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. McCain gives $5 million to St. Michael’s Hospital for therapeutic endoscopy
2. Researchers discover possible biomarker and therapeutic target for melanoma
3. Study identifies therapeutic target for liver cancer and predictive biomarker of response
4. Therapeutic lifestyle changes as useful as drugs in improving mental health
5. Mayo Clinic researchers confirm value of therapeutic hypothermia after cardiac arrest
6. Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures
7. Save messengers -- modified mRNAs open up new therapeutic possibilities
8. Transplanted human placenta-derived stem cells show therapeutic potential in stroke models
9. Optimizing patient outcomes after therapeutic hypothermia for traumatic brain injury
10. Does Club Drug Ecstasy Have Therapeutic Value?
11. Autism Consortium 2010 Symposium: New therapeutics focus, family resource guide announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... ... physicians in eight Bay Area counties for 2017. Almost 1,000 nominations were submitted ... managing the award process. Results were announced the magazine’s January 2017 issue ...
(Date:1/14/2017)... ... 14, 2017 , ... Healthy living brand Moody Zook recently ... products. With more and more people opting to go organic in their lifestyle, ... cater to specific needs. , Moody Zook focused particularly on their newly launched ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... sugar levels. Counting carbohydrates is as easy as checking the nutrition label on ... affects blood sugar levels. Despite being sugar-free, proteins can influence — either positively ...
(Date:1/13/2017)... ... January 13, 2017 , ... With the increasing public preference ... providing additional organic alternatives for customers who have grown more conscious about maintaining ... of all-natural activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained ...
(Date:1/13/2017)... ... ... "We wanted to create a design for orthodontic appliances that would make ... Beach, Va. , They created a prototype for the patent-pending BRACE FACERS to add ... be customized to suit personal tastes. They can be used to create custom designs ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... January 13, 2017 Constant research ongoing ... will collectively contribute to the demand for western blotting technique. ... value of US$ 551.0 Mn by 2016 end. Developing economies ... most lucrative markets for western blotting, whereas North ... ...
(Date:1/13/2017)... NEW YORK , January 13, 2017 ... Biotech equities to see how they have fared at ... CLVS ), Galena Biopharma Inc. (NASDAQ: GALE ... ). These companies harness cellular and biomolecular processes to ... diseases, reduce our environmental footprint, feed the hungry, use ...
(Date:1/13/2017)... 2017   JDRF , the leading global ... pleased to announce that after more than a ... & Medicaid Services (CMS) has recognized continuous glucose ... use in making diabetes treatment decisions as durable ... eligible for coverage under Medicare. JDRF has been ...
Breaking Medicine Technology: